US Patent 8003819 Proteasome inhibitors
Patent 8003819 was granted and assigned to Millennium Pharmaceuticals on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+268 characters)
Article
Patent abstract
The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Edward J. Olhava0
Mihaela Diana Danca0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08003819 Proteasome inhibitors US Patent 8003819 Proteasome inhibitors
Infobox
Patent Number
080038190
Patent Number
80038190
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080038190
Date of Patent
August 23, 2011
0Patent Application Number
127048300
Date Filed
February 12, 2010
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08003819 Proteasome inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08003819
Date of patent
August 23, 2011
Patent application number
12704830
Date Filed
February 12, 2010
Patent primary examiner
Find more entities like US Patent 8003819 Proteasome inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
